Edition:
United States

Guizhou Yibai Pharmaceutical Co Ltd (600594.SS)

600594.SS on Shanghai Stock Exchange

16.39CNY
28 Apr 2017
Change (% chg)

¥-0.02 (-0.12%)
Prev Close
¥16.41
Open
¥16.52
Day's High
¥16.54
Day's Low
¥16.30
Volume
6,698,610
Avg. Vol
13,664,499
52-wk High
¥20.30
52-wk Low
¥14.12

600594.SS

Chart for 600594.SS

About

GUIZHOU YIBAI PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The company's products are... (more)

Overall

Beta: 0.84
Market Cap(Mil.): ¥12,971.77
Shares Outstanding(Mil.): 791.93
Dividend: 0.06
Yield (%): 0.12

Financials

  600594.SS Industry Sector
P/E (TTM): 40.86 29.08 30.08
EPS (TTM): 0.40 -- --
ROI: 8.01 13.73 13.25
ROE: 8.59 14.68 14.41

BRIEF-Guizhou Yibai Pharmaceutical to pay cash 0.6 yuan per 10 shares as FY 2016 div payment

* Says it plans to pay cash 0.6 yuan per 10 shares as FY 2016 div payment

Apr 27 2017

BRIEF-Guizhou Yibai Pharma to acquire stake in a Sichuan-based hospital

* Says it signs agreement to acquire 90 percent stake in a Sichuan-based hospital for 135.0 million yuan ($19.63 million)

Feb 20 2017

BRIEF-Guizhou Yibai Pharmaceutical sees FY 2016 net profit up 100 pct to 120 pct

* Sees net profit for FY 2016 to increase by 100 percent to 120 percent

Jan 26 2017

BRIEF-Guizhou Yibai Pharmaceutical unit plans medical JV, with partners

* Says its unit plans to invest 5.1 million yuan to set up a medical JV, with partners

Nov 28 2016

BRIEF-Guizhou Yibai Pharmaceutical to boost capital in Nanjing investment firm

* Says co plans to inject capital of 56 million yuan in a Nanjing-based investment management firm and will hold a 51 percent stake up from 0 percent after transaction

Nov 06 2016

BRIEF-Guizhou Yibai Pharmaceutical unit to raise stake in tumor medical tech firm to 51 pct

* Says its unit plans to inject capital of 51 million yuan in a Sichuan tumor medical tech firm, jointly with 4 individuals

Nov 06 2016

BRIEF-GuiZhou YiBai Pharmaceutical sees 2016 net profit to rise more than 100 pct y/y

* sees 2016 net profit to rise more than 100 percent y/y, due to optimization of marketing management and marketing expense control

Oct 30 2016

More From Around the Web

Earnings vs. Estimates